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ABSTRACT
Objective: The prevalence of cardiovascular disease is
increasing dramatically partially because of the alarming rise
in overweight/obesity, diabetes, and related cardiovascular
risk factors such as hypertension and hyperlipidemia. These
risk factors are often preventable and usually cluster
together. The purpose of this study was to examine and
quantify the impact of cardiovascular risk factor clusters
(CVRFC) on employment in the United States.
Methods: Using the nationally representative Medical
Expenditure Panel Survey, the current research estimated the
likelihood of employment and the impact on annual wages
using a recursive bivariate probit model and a Heckman
selection model, controlling for sociodemographic character-
istics, smoking status, marital status, and geographic region.
CVRFC included body mass index (BMI) ≥ 25 or BMI ≥ 30
with two of the following three: diabetes, hyperlipidemia
and/or hypertension. All estimates were expressed in 2005
US dollars.
Results: Unadjusted analyses suggest that less than half of
individuals with CVRFC were employed compared with
74% on average in the United States. Results of the bivariate
probit analysis suggested that individuals with CVRFC were
40% (using BMI ≥ 25) and 45% (BMI ≥ 30) less likely to be
employed than those without.
Conclusions: Common CVRFC have a signiﬁcant deleteri-
ous impact on employment in the United States. Employers,
medical professionals, and public health programs need to
address this problem and institute treatment strategies and
prevention efforts to mitigate the deleterious impact on soci-
etal productivity in the United States.
Keywords: bivariate probit model, cardiometabolic risk fac-
tors, employment, income.
Background
Previous research has shown that cardiovascular
disease has a signiﬁcant and deleterious impact on
employment and productivity [1–8]. The burden
attributable to cardiovascular diseases translates into
signiﬁcant lost productivity and economic cost. Cardi-
ovascular disease costs $152 billion in lost productiv-
ity and $242 billion in direct medical expenditures
annually, resulting in a total estimated cost of $393.5
billion to the US economy in 2005 (2005 $US) [9]. It is
the leading cause of death and morbidity in the United
States, causing more than 40% of all deaths [10].
Because of the alarming rise in overweight/obesity,
diabetes, and related cardiovascular risk factors such
as hypertension and hyperlipidemia, coupled with the
aging demographic shift of the population, the preva-
lence of cardiovascular disease will likely continue to
increase dramatically [11]. Nevertheless, cardiovascu-
lar disease may be largely preventable and efforts have
been made to identify, prevent, and treat key risk fac-
tors. Certain risk factors often cluster together in the
same individual, such as overweight/obesity (particu-
larly abdominal obesity), diabetes, hyperlipidemia,
and hypertension [9,12,13]. Overt cardiovascular
disease has a negative impact on employment and
income. Although data are available on the impact of
overt cardiovascular disease, little is known about the
income and employment characteristics and effects
of these common cardiovascular risk factor clusters
(CVRFC). The purpose of the current study is to deter-
mine whether these common constellations of CVRFC,
before the overt development of cardiovascular dis-
ease, have a deleterious impact on wages and employ-
ment status in a nationally representative sample of US
adults.
Methods
Data Source
The Medical Expenditure Panel Survey (MEPS) is
based on the sampling frame for the National Health
Interview Survey (NHIS) and provides a nationally
representative sample of the US civilian noninstitution-
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alized population. MEPS is based on self-report and
includes detailed information on age, sex, race and eth-
nicity, education, employment status, wages, annual
income, and health conditions [14]. The sample design
includes stratiﬁcation, clustering, multiple stages of
selection, and disproportionate sampling [15]. The
sample base of MEPS provides oversampling of His-
panics and African Americans to ensure representa-
tion. MEPS sampling weights incorporate adjustment
for the oversampling of African Americans and His-
panics, the complex sample design, and survey nonre-
sponse to ensure accurate reﬂection of US population
totals from the Current Population Survey. The current
research used the 2000 and 2002 MEPS public use
data to provide a larger sample on individuals that do
not overlap (the MEPS 2001 data has panels that over-
lap with 2000 and 2002) [14]. MEPS is a widely used
public health data set in the United States because it
contains nationally representative and detailed infor-
mation about medical utilization and expenditures,
demographic and socioeconomic characteristics, med-
ical conditions, employment, and missed work [14].
Limitations associated with MEPS are delineated in the
Discussion section.
Employment status and total annual wages were the
main outcomes of interest. An individual who was
employed at any point of time during the year was
classiﬁed as being employed in MEPS. Annual wages
included all income from salary and wages.
Cardiovascular Risk Factor Clusters
Body mass index (BMI) was calculated from body
weight and height, using the following formula (from
the Centers for Disease Control and Prevention,
http://www.cdc.gov/): BMI = [Weight in Pounds/
(Height in Inches)2] * 703. Full documentation is pro-
vided on page 97 of the MEPS H60 documentation ﬁle
[14]. Height, weight, medical conditions, and sociode-
mographic characteristics were based on self-report in
the MEPS Household Component survey. Individuals
were considered to have CVRFC if they had BMI ≥ 25
and any two of the following three risk factors: hyper-
tension, hyperlipidemia and/or diabetes. In addition, a
second analysis included BMI ≥ 30 with two of the
three listed cardiovascular risk factors. Respondents
were asked whether they had ever been diagnosed as
having diabetes (excluding gestational diabetes) and
whether they had been told on two or more different
medical visits that they had high blood pressure. MEPS
mapped medical conditions to three-digit ICD-9 codes
based on self-report and medical and pharmacy utili-
zation. MEPS then used 259 mutually exclusive
Clinical Classiﬁcation Categories (CCC), which were
mapped from ICD-9 codes to provide clinically
homogenous groupings [14,16]. The ICD-9 to CCC
crosswalk is available at: http://www.meps.ahrq [14].
CCC 053 “Disorders of Lipid Metabolism” was used
to identify individuals with dyslipimdemia. Although
there is some controversy about whether common
clusters of cardiovascular risk factors reﬂect an under-
lying syndrome thought to be related to insulin re-
sistance (commonly referred to as the “metabolic
syndrome”), it is clear from decades of research on car-
diovascular disease that diabetes, hypertension, hyper-
lipidemia, and overweight/obesity are prone to cluster
together and result in an elevated risk of cardiovascu-
lar disease [9,12]. This research focused on these com-
mon clusters of cardiovascular risk factors.
Several comorbidity, socioeconomic, and demo-
graphic characteristics were included to control for
confounding in the multivariate analyses. By adding
the total number of chronic ICD-9 codes reported for
each individual, a measure of comorbidity burden was
derived by combining the total number of chronic con-
ditions for each individual minus hypertension, dysli-
pidemia, and diabetes. The following variables were
measured categorically: age (18–29, 30–39, 40–49,
50–59, 60–69, 70–79, ≥80); level of education (less
than high school degree, high school degree, other
degree, Bachelor’s degree, and Master’s degree or
PhD); family income as a percent of the federal poverty
line (poor/negative, near poor, low income, middle
income, high income: the federal poverty line varies by
geographic location and number of family members—
the federal poverty line for a family of four in the 48
contiguous states was $19,350 in 2005); race (Cauca-
sian, African American, American Indian, or other);
ethnicity (Hispanic or non-Hispanic); married versus
not married; geographic region (East, Midwest, South,
and West); and current smoker (Yes/No).
Statistical Analysis
Cardiovascular risk factor clusters and employment
are deﬁned as dichotomous variables. It is possible that
unobserved variables may affect both the propensity to
develop CVRFC and the likelihood of unemployment.
For example, personal characteristics or genetic char-
acteristics are not observed but could lead an individ-
ual to have both a lower likelihood of employment as
well as behavioral habits that lead to the development
of CVRFC. Our approach uses recursive bivariate pro-
bit analysis to estimate the impact of CVRFC on the
likelihood of employment. This approach allows for
the correction of possible unobserved heterogeneity
and simultaneity. Using maximum-likelihood simulta-
neous estimation of the two probit equations, we test
for exogeneity using recursive bivariate probit analysis
[17]. Using the joint estimation, we calculate the mar-
ginal effect of CVRFC on the likelihood of employ-
ment. More speciﬁcally, the simultaneous equation
approach includes a reduced form equation for
the potentially endogenous dichotomous variable
(CVRFC) and a structural form equation for the like-
lihood of employment as follows [17]:
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 = β1X1i + u1i
 = δ1q1i + δ2Z2i + u2i
Where  and  are latent dichotomous variables
(CVRFC and employment, respectively), q1i is the
endogenous dichotomous variable, CVRFC, X1i, and
Z2i are exogenous variables and β1, δ1, and δ2 are the
vectors of unknown parameters to be estimated. In the
current model speciﬁcation, X1i includes age, sex, eth-
nicity, race, education, and income; while Z2i includes
age, sex, ethnicity, race, education, chronic comorbid-
ity burden, smoking status, marital status, and geo-
graphic region. The error terms of the two models
are dependent and distributed as bivariate normal so
that E(u1i) = E(u2i) = 0 and var(u1i) = var (u2i) = 1 and
cov(u1i, u2i) = ρ. If ρ = 0 then q1i is exogenous in the
second equation and the recursive bivariate probit
approach is not necessary. The Wald test provides evi-
dence of a signiﬁcant non-zero correlation between the
unobserved explanatory variables in both equations.
Using the results of joint estimation, we calculate four
predicted probabilities: employed and has CVRFC
(p11), employed and does not have CVRFC (p10),
unemployed and has CVRFC (p01), and unemployed
and does not have CVRFC (p00). From the joint
probabilities, we can calculate the marginal effect of
CVRFC. This estimate represents the marginal effect of
having CVRFC on the probability of being employed.
In order to estimate the impact of CVRFC on
annual wages, a maximum-likelihood Heckman selec-
tion model was used with logarithmic transformation
of annual wages and smearing re-transformation using
the naïve (normal) assumption for residuals [18,19]. A
two-part model structure is necessary to measure the
impact of CVRFC on annual wages, conditional on
individuals being employed. To ensure that all esti-
mates were expressed in a common year, income data
were inﬂated to 2005 US dollars using the Consumer
Price Index [20]. The selection model simultaneously
estimates the impact of CVRFC, age, sex, ethnicity,
race, education, chronic comorbidity burden, smoking
status, marital status, and geographic region on the
likelihood of receiving wage income and the impact of
CVRFC, age, sex, ethnicity, race, education, chronic
comorbidity burden, and geographic region (condi-
tional on receiving wage income) on the log of annual
wages.
All analyses incorporated MEPS sampling and var-
iance adjustment weights to ensure nationally repre-
sentative estimates.
Results
The prevalence of CVRFC increases with increasing
age, male sex, African American race, and lower levels
of income and education (Table 1). The prevalence
of individual risk factors, particularly overweight
q*1i
q*2i
q*1i q*2i
(BMI ≥ 25), obesity (BMI ≥ 30), hypertension, and
diabetes, appears to be greater among those with lower
levels of education and income and older adults. In
unadjusted analyses, individuals with CVRFC appear
to be less likely to be employed and have lower annual
incomes when compared with those without CVRFC
and with the US average (Table 2). For example, indi-
viduals with CVRFC (using BMI ≥ 25 as the criterion)
made $17,620 annually compared with $27,106 for
those without and only 45% of individuals with
CVRFC were employed compared with 76% of those
without and 74% in the US population on average.
Interestingly, individuals with CVRFC using BMI ≥ 30
as the criterion were slightly more likely to be
employed and had higher annual wages than those
with CVRFC using BMI ≥ 25 as the criterion. This is
an unexpected ﬁnding. Nevertheless, these analyses
were unadjusted. It is possible that the higher employ-
ment rates for BMI ≥ 30 could simply reﬂect the fact
that individuals with CVRFC using BMI ≥ 30 as the
criterion were more likely to be of working age than
those falling under the criterion of BMI ≥ 25.
Results from the recursive bivariate probit analysis
suggest that individuals with CVRFC (with BMI ≥ 25
as the criterion) are 40% less likely to be employed
after incorporating the possibility of endogeneity
and controlling for sociodemographic characteristics,
comorbidity, smoking status, marital status, and geo-
graphic region. This means that if the likelihood of be-
ing employed for individuals without CVRFC is 76%,
then the likelihood for individuals with CVRFC (with
BMI ≥ 25 as the criterion) is 46% (which is 40% lower
than 76%). Using BMI ≥ 30 as the criterion results in
individuals being 45% less likely to be employed. The
Wald test (P < 0.0000) suggested that there was corre-
lation between the unobserved explanatory variables
in both equations and that the recursive bivariate pro-
bit approach was necessary to address the endogeneity
in the model. Using the results of joint estimation, four
predicted probabilities were calculated: employed and
has CVRFC (p11 = 0.026), employed and does not
have CVRFC (p10 = 0.711), unemployed and has
CVRFC (p01 = 0.009), and unemployed and does not
have CVRFC (p00 = 0.25). From the joint probabili-
ties, the marginal effect of CVRFC was calculated as −
0.395 and −0.448, using BMI ≥ 25 and BMI ≥ 30 as
the criterion, respectively.
The results of the Heckman selection model suggest
that individuals with CVRFC (BMI ≥ 25) are indeed
less likely to be employed; however, when employed,
having CVRFC does not have a signiﬁcant impact on
the level of wage income. Thus, the ﬁrst ﬁnding con-
ﬁrms the result of the bivariate probit model that indi-
viduals with CVRFC are less likely to be employed.
The second ﬁnding is that there is no wage discrimi-
nation for individuals with CVRFC. Hence, those indi-
viduals with CVRFC who do ﬁnd and retain gainful
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employment do not make less in annual wages than
employed individuals without CVRFC (the coefﬁcient
of CVRFC in the log wage equation of the selection
model was not statistically signiﬁcant). The results
were the same using BMI ≥ 30 as the criterion.
Discussion
The prevalence of CVRFC is increasing signiﬁcantly
for almost every demographic group in the United
States [9,13]. The results of this study highlight the
negative impact of CVRFC on employment. After
controlling for differences in sociodemographics,
smoking, marital status, geographic region, and
comorbidity burden, individuals with CVRFC were
40% (using BMI ≥ 25 as the criterion) and 45% (using
BMI ≥ 30) less likely to be employed than those with-
out CVRFC. Although annual wages were signiﬁcantly
lower for individuals with CVRFC in the unadjusted
analysis, this appears to be due to their lower likeli-
Table 1 Cardiovascular risk factor clusters*† and risk factor prevalence (%) by income, education, and demographic characteristics
(MEPS 2000 and 2002)
Population
Prevalence
of CVRFC*
Prevalence
of CVRFC†
Prevalence
BMI ≥ 25
Prevalence
BMI ≥ 30
Prevalence of
hyperlipidemia
Prevalence of
hypertension
Prevalence
of diabetes
Income
Poor/negative 6.76 3.96 59.30 28.15 6.94 23.43 7.85
Near poor 9.73 5.48 61.31 28.06 8.02 26.33 11.06
Low income 7.84 3.88 60.43 25.34 8.16 23.81 8.84
Middle income 5.98 3.06 60.12 24.69 8.23 19.51 6.09
High income 5.62 2.84 57.31 20.32 9.52 18.22 4.84
Level of education
No degree 8.08 4.30 59.44 25.94 7.89 24.96 9.40
High school degree 6.46 3.43 60.96 25.35 8.68 20.59 6.10
Other degree 5.13 3.04 60.51 24.81 8.59 18.35 4.92
Bachelor’s degree 4.58 2.09 53.86 17.75 8.25 14.99 4.68
MA or PhD 5.23 2.24 52.88 14.96 10.88 18.13 4.05
Age (years)
18–19 0.00 0.00 31.36 11.02 0.06 0.44 0.66
20–29 0.25 0.19 48.17 18.44 0.36 2.21 0.87
30–39 1.00 0.72 59.92 24.37 2.26 6.49 1.96
40–49 4.11 2.52 64.97 26.44 6.71 15.61 4.15
50–59 9.81 5.72 65.96 27.75 13.28 29.77 9.39
60–69 17.14 8.72 67.41 27.21 22.26 43.74 14.83
70–79 18.61 7.90 60.85 22.31 22.95 51.89 17.30
≥80 12.68 4.53 46.96 13.55 15.80 55.47 14.30
Sex
Female 5.76 3.22 52.08 23.78 7.74 21.12 6.29
Male 6.86 3.30 66.25 23.04 9.57 19.19 6.29
Race
White 6.23 3.13 58.66 22.66 9.15 19.80 5.90
African American 7.64 4.83 68.78 33.67 5.48 25.30 9.11
American Indian 6.26 3.39 70.00 34.96 5.08 21.63 8.66
Other race 4.05 1.61 37.63 9.53 7.65 13.97 5.90
Hispanic ethnicity
Non-Hispanic 6.58 3.43 58.09 23.07 9.22 21.20 6.23
Hispanic 4.05 1.90 65.68 26.17 3.95 12.17 6.79
MEPS
Total N = 43,221 6.29 3.26 58.95 23.42 8.62 20.18 6.29
*CVRFC = BMI ≥ 25 and 2 of the 3 following risk factors: diabetes, hypertension and/or hyperlipidemia.
†CVRFC = BMI ≥ 30 and 2 of the 3 following risk factors: diabetes, hypertension and/or hyperlipidemia.
BMI, body mass index; CVRFC, cardiovascular risk factor clusters; MEPS, the Medical Expenditure Panel Survey.
Table 2 Unadjusted percent of population employed and reported annual wage in the United States (MEPS 2000 and 2002 with
valid BMI)
US average
per person
With CVRFC
(BMI ≥ 25)*
per person
With CVRFC
(BMI ≥ 30)†
per person
Without 
CVRFC 
per person
% of population employed 73.7 44.9 47.68 75.7
MEPS reported annual wage (2005 $US) 26,509 17,620 18,444 27,106
*CVRFC = BMI ≥ 25 and 2 of the 3 following risk factors: diabetes, hypertension and/or hyperlipidemia.
†CVRFC = BMI ≥ 30 and 2 of the 3 following risk factors: diabetes, hypertension and/or hyperlipidemia.
BMI, body mass index; CVRFC, cardiovascular risk factor clusters; MEPS, the Medical Expenditure Panel Survey.
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hood of being employed rather than lower compensa-
tion or discrimination for those who are employed.
Data on the employment and wage impact of
CVRFC are limited; however, previous studies have
examined the individual effects of diabetes, obesity
and the major sequela of CVRFC, cardiovascular
disease, on employment and productivity [1–8,21].
Tunceli et al. found that the absolute probability of
working was lower for men and women with diabetes
compared with that of their counterparts without dia-
betes in the Health and Retirement Study (HRS) [22].
In addition to increased sick days and disability, Vijan
et al. found diabetes to be a signiﬁcant predictor of
early retirement and mortality in the HRS [23]. In
addition, Finkelstein has reported that obesity is cor-
related with increased absenteeism in the United States
[21]. Studies have also examined the impact of cardi-
ovascular disease on employment and income. Zwer-
ling et al. showed that persons with disabilities related
to cardiovascular disease were less likely to be
employed using the NHIS [2]. Grover et al. found that
individuals with cardiovascular disease earned less in
annual income than those without [3]. Nevertheless,
they did not use a selection model to determine
whether annual income was lower for those who were
employed and it is not clear whether the lower income
attributable to cardiovascular disease was an artifact
of lower employment rates as found in the current
study. In conclusion, there is evidence that individual
cardiovascular risk factors have a negative impact on
employment and productivity in the United States. It is
also clear that the major consequence of CVRFC, car-
diovascular disease, has a deleterious impact on the
likelihood of employment and productivity. The cur-
rent study adds to this body of literature in quantifying
the negative impact of CVRFC on the likelihood of
employment.
The results of this study show that individuals with
CVRFC have a relative decrease in the likelihood of
employment of 40% and 45% (using BMI ≥ 25 and
BMI ≥ 30 as the criterion, respectively). Given that the
unadjusted percent of the population employed was
75.7% (Table 2) for individuals without CVRFC in the
United States, this equates to an absolute reduction of
30.3% and 34.1%, for BMI ≥ 25 and BMI ≥ 30,
respectively. Interestingly, after controlling for poten-
tial endogeneity and differences in sociodemographics,
smoking, marital status, geographic region, and
comorbidity burden in the recursive bivariate probit
analysis, the predicted percent of the population
employed with CVRFC (using BMI ≥ 25 as the crite-
rion) was 45.4%, compared with 44.9% in the unad-
justed analysis (Table 2). This suggests that less than
half of the population with CVRFC are employed.
This research is not without limitations. Although
it is evident that overweight/obesity, hypertension,
hyperlipidemia, and diabetes tend to cluster together
for many individuals, there is some controversy as to
whether or not these CVRFC reﬂect an underlying syn-
drome related to insulin resistance (the “metabolic
syndrome”) or simply that these risk factors cluster
together [12]. This analysis assesses the impact of com-
mon CVRFC without assumptions about underlying
pathophysiology. The current analysis sought to make
a comparison between individuals with CVRFC and
those without. Although beyond the scope of this anal-
ysis, future research would beneﬁt from a comparison
between each individual risk factor and the sum of all
risk factors to determine whether the impact of the
sum is greater than the impact of the individual parts.
Abdominal obesity is a strong predictor of cardio-
vascular risk. Nevertheless, MEPS does not contain
information about waist circumference, which may be
preferable to BMI as a more speciﬁc measure of
abdominal obesity. Information about employment
status was based on self-report, which may introduce
bias in the results. In addition, medical conditions used
in this research are based on self-report and there is
evidence that self-reported conditions tend to be
underreported [24–27]. Overweight respondents also
tend to underestimate their weight and overestimate
their height [28,29]. MEPS does not contain informa-
tion on laboratory values and thus does not capture
undiagnosed diabetes, hypertension, or hyperlipi-
demia. Recent estimates suggest that approximately
35% of individuals with diabetes have not been diag-
nosed [30]. As a result, it is likely that the presence of
CVRFC is underestimated, and hence, its impact on
employment may be underestimated to a commensu-
rate degree.
Despite the limitations, the results of this research
are nationally representative and efforts were made to
control for potential endogeneity and sample selection
in the employment and wage models. The results
clearly demonstrate the deleterious impact of CVRFC
on societal productivity in the United States and pro-
vide further evidence of the urgent need for prevention
and public health strategies to combat the explosive
rise in the prevalence of these CVRFC. In the United
States, persons with chronic diseases in general are less
likely to participate in the labor force, and if employed,
many of them experience difﬁculties in performing
physical, psychosocial, or environmental work
demands, which may contribute to lower employment
rates [31]. The severity of functional impairments, psy-
chological factors, attitudes, and beliefs related to
chronic disease may impact the decision and ability to
obtain and maintain employment [32]. The medical
profession should pay closer attention to the impact of
CVRFC on work-related characteristics when interact-
ing and treating patients with these risk factor clusters.
In addition, prevention and treatment of CVRFC
should improve the ability of individuals to ﬁnd
and retain gainful employment. Given the explosive
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increase in the incidence of CVRFC, and the obvious
negative impact on productivity in the United States, it
is imperative that a multifaceted approach to combat
this trend be undertaken. Employers, medical profes-
sionals, and public health programs need to address
this problem and institute treatment strategies and pre-
vention efforts to mitigate the deleterious impact on
societal productivity in the United States.
Statistical output available upon request from the authors.
Source of ﬁnancial support: This research was supported by
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